Package Leaflet: Information for the User
Midazolam Accord 1 mg/ml Solution for Injection and InfusionEFG
Read all of this leaflet carefully before you are given this medicine, because it contains important information for you.
Contents of the Pack
Midazolam solution for injection and infusion contains midazolam which belongs to a group of medicines known as benzodiazepines.
This is a short-acting medicine used to induce sedation (a state of calm, drowsiness or sleep) and to relieve anxiety and muscle tension.
This medicine is used for:
Do not use Midazolam Accord
You must not be given midazolam if any of the above applies to you. If you are not sure, talk to your doctor or nurse before you are given this medicine.
Warnings and precautions
Adults
Before you are given midazolam, tell your doctor or nurse if you:
Children and babies
If your child is going to be given this medicine:
Talk to the doctor or nurse if any of the above applies to your child.
Using Midazolam with other medicines
Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines, including those obtained without a prescription and herbal medicines.
This is especially important because using more than one medicine at the same time can increase or decrease the effect of the medicines in question.
In particular, tell your doctor or nurse if you are taking any of the following medicines:
If you are in any of these situations (or are unsure), talk to your doctor or nurse before you start using Midazolam Accord.
Surgery
If you are going to have an anaesthetic for an operation or for dental treatment (including inhaled anaesthetics that you breathe in), it is important that you tell your doctor or dentist that you have been using midazolam.
Midazolam Accord with alcohol
Do not drink alcohol if you have been given midazolam. This is because alcohol can increase the sedative effect of midazolam and can cause breathing problems.
Pregnancy and breast-feeding
Tell your doctor if you are pregnant, think you may be pregnant or plan to become pregnant. Your doctor will decide whether this medicine is suitable for you.
Midazolam may harm your baby if it is given at the start of pregnancy. When high doses are given during the late stage of pregnancy, labour or caesarean section, there may be a risk of inhalation and your baby may have irregular heartbeats, low muscle tone (hypotonia), feeding difficulties, low body temperature and breathing difficulties. With prolonged use during the end of pregnancy, your baby may become physically dependent and be at risk of withdrawal symptoms after birth.
Driving and using machines
This medicine may cause drowsiness, dizziness, loss of memory or affect your concentration and coordination. This may reduce your ability to perform tasks that require a specific skill, such as driving or operating machinery. Do not drive a vehicle or operate machinery until you have fully recovered. Your doctor will tell you when you can resume these activities.
Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine.
Lack of sleep or drinking alcohol may further affect your state of alertness.
You should always be taken home by a responsible adult after your treatment.
Midazolam Accord contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per ampoule, which is essentially "sodium-free".
Midazolam should only be given by healthcare professionals with experience (doctor or nurse). It should be given in a place (hospital, clinic or operating theatre) equipped to monitor and maintain your breathing, heart and circulation (cardiovascular function) and to recognise and control the expected side effects of anaesthesia.
How much midazolam will be given to you
Your doctor will decide on a suitable dose for you. The dose you are given will depend on why you are being treated and the type of sedation needed. Your weight, age, state of health, how you respond to midazolam and whether you need other medicines at the same time will also affect the dose you are given.
If you need strong painkillers, these will be given to you first and then you will be given midazolam. Your doctor will decide on a suitable dose for you.
How midazolam will be given to you
Midazolam can be given to you in four different ways:
You should always be taken home by a responsible adult after your treatment.
Children and babies
If you are given too much Midazolam Accord
Your medicine will be given to you by a doctor or nurse.
If you are accidentally given too much midazolam, you may:
Stopping treatment with midazolam
If you receive midazolam treatment for a long time (you are given the medicine for a long time), you may:
Become tolerant to midazolam. The medicine becomes less effective and does not work as well for you.
Become dependent on this medicine and have withdrawal symptoms (see below).
Your doctor will gradually reduce your dose to avoid these effects.
The following effects have been seen with the use of midazolam, particularly in children and elderly patients: restlessness, agitation, irritability, involuntary movements, hyperactivity, nervousness, hostility, delirium, anger, aggression, anxiety, nightmares, hallucinations (seeing and possibly hearing things that are not really there), psychosis (loss of contact with reality) and inappropriate behaviour, excitement and fits (these reactions are also known as paradoxical reactions, which are opposite to the effects that are normally expected for the medicine). If you experience these effects, your doctor will consider stopping treatment with midazolam.
Withdrawal symptoms:
Benzodiazepine medicines, such as midazolam, can make you dependent if they are used for a long time (for example, in intensive care). This means that if you stop treatment suddenly or reduce the dose too quickly, you may have withdrawal symptoms. The symptoms can include:
In severe cases of withdrawal, the following may occur: feeling of loss of contact with reality, numbness and tingling of the limbs (for example, hands and feet), sensitivity to light, noise and touch.
Like all medicines, Midazolam Accord 1 mg/ml can cause side effects, although not everybody gets them. The following side effects have been seen with this medicine (frequency not known).
Do not use midazolam and see a doctor urgently if you notice any of the following side effects. These could be life-threatening and may need urgent medical treatment:
Life-threatening side effects are more common in adults over 60 years and those patients who already have breathing difficulties or heart problems, particularly if the injection is given too quickly or at a high dose.
Other possible side effects
Immune system disorders:
|
Effects on behaviour:
Nervous system disorders:
Cardiovascular disorders:
Respiratory disorders:
Gastrointestinal disorders:
Skin disorders:
Muscle disorders:
Injection site disorders:
Injury:
General disorders:
Elderly patients:
Life-threatening side effects are more likely to occur in adults over 60 years and those patients who already have breathing difficulties or heart problems, particularly when the injection is given too quickly or at a high dose.
Patient with severe kidney disease:
Patient with severe kidney disease are more likely to experience side effects.
If any of the side effects get serious or if you notice any side effects not listed in this leaflet, please tell your doctor or nurse.
Reporting of side effects
If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Your doctor or pharmacist is responsible for storing midazolam. The storage details are as follows:
Composition of Midazolam Accord1 mg/ml
The active ingredient is midazolam (as midazolam hydrochloride).
Each ml of injectable solution contains 1 mg of midazolam (as midazolam hydrochloride).
Each 5 ml ampoule contains 5 mg of midazolam (as midazolam hydrochloride)
The other components are water for injectables, sodium chloride, sodium hydroxide (to adjust pH), and concentrated hydrochloric acid (to adjust pH).
Appearance of the Product and Package Contents
Midazolam Accord 1 mg/ml is a clear, colorless to pale yellow solution, packaged in a transparent glass ampoule.
Midazolam Accord 1 mg/ml is available in packs of 10 ampoules of 5 ml.
The ampoules are available in a blister/tray package.
Marketing Authorization Holder
Accord Healthcare S.L.U.
World Trade Center
Moll de Barcelona s/n,
Edifici Est, 6ª planta
08039 Barcelona
Spain
Manufacturer
Accord Healthcare Polska Sp.z o.o.,
ul. Lutomierska 50,95-200 Pabianice,
Poland
Date of Last Revision of this Leaflet:July 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
This information is intended only for doctors or healthcare professionals:
Preparation of the Solution for Infusion
Midazolam Accord can be diluted with a 0.9% sodium chloride solution, 5% or 10% glucose solution, Ringer's solution, or Hartmann's solution. In the case of continuous intravenous infusion, it can be diluted in the range of 0.015 to 0.15 mg per ml with one of the solutions mentioned above. These solutions remain stable for 24 hours at room temperature and for 3 days at 8°C. Midazolam Accord should not be mixed with any solution other than those listed above. In particular, midazolam should not be diluted with 6% dextran (with 0.9% sodium chloride) in glucose or mixed with an injection of an alkaline compound. Midazolam precipitates in hydrogen carbonate.
The injectable or infusion solution should be visually examined before administration. Only solutions without visible particles will be used.
Validity Period and Storage
Midazolam Accord is designed for single use.
Ampoule before opening
Store in the original packaging to protect it from light.
Ampoule after dilution
Physical-chemical stability has been demonstrated in use conditions for the dilutions for 24 hours at room temperature (15°C-25°C) or for 3 days at 8°C.
From a microbiological point of view, the product should be used immediately. If not used immediately, the storage times under use conditions and the conditions prior to use will be the responsibility of the user and will generally not exceed 24 hours at 2-8°C, unless the dilution has taken place in controlled and validated aseptic conditions.
In the case of continuous intravenous infusion, it can be diluted in the range of 0.015 to 0.15 mg per ml with one of the solutions mentioned above.
Disposal of Waste Products
Any unused medicine or waste material should be disposed of in accordance with local regulations.